Nabumetone Tillomed

Nabumetone, the active ingredient in Nabumetone Tillomed, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and acute pain in adults.

GNH USA supplies Nabumetone Tillomed as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nabumetone is an NSAID used to manage inflammatory joint diseases and short‑term pain. - Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint pain and enhances functional ability. - Ankylosing spondylitis: decreases spinal inflammation and stiffness. - Acute pain: provides short‑term relief of moderate pain from injuries or procedures.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: dyspepsia, nausea, or abdominal pain. - Diarrhea: loose stools occurring during treatment. - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening. - Hepatic injury: elevated liver enzymes or hepatitis. - Renal impairment: reduced kidney function or acute renal failure. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: acute allergic reaction with respiratory compromise. - Cardiovascular events: increased risk of thrombotic events in susceptible patients.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Renal function: assess baseline creatinine and monitor periodically. - Hepatic enzymes: check liver function tests before and during treatment. - Gastrointestinal risk: avoid in patients with active peptic ulcer disease. - Concomitant anticoagulants: use caution due to increased bleeding risk. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nabumetone may interact with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: increased lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - ACE inhibitors or ARBs: potential for renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal effects. - Corticosteroids: increased risk of ulceration. - SSRIs: modest increase in bleeding tendency. - Antihypertensives: possible reduction in blood pressure control. - Oral hypoglycemics: may affect glucose regulation.